Atlas Trials

Study to Assess the Effect of Omecamtiv Mecarbil (OM) on QT/QTc Intervals in Healthy Adults

Clinical trial NCT04175808 · COMPLETED

Trial details

NCT number
NCT04175808
Sponsor
Cytokinetics
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
QT Intervals ChangesQTc Intervals Changes
Start date
2019-11-14
Primary completion
2020-03-04
Enrollment
70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.